Results High glucose induced the decrease in viability of H9c2 cells: The viability of high glucose cells at 12, 24, and 48 mmol/L was [(79.5±2.23)%] (t = 3.143, P = 0.043), [(54.6±3.08)%] (t = 12.425, P = 0.000) and [(37.2±2.59)%] (t = 13.761, P = 0.000) of the control group (100%) . Compared with the control group (100%), the cell viability of the mannitol isotonic control group was [(101.0±1.27)%] (t = 0.012, P = 0.094). High glucose induced the increase of hoechst 33258 positive cells in H9c2 cells and increased the expression of pro-apoptotic protein Bax: Compared with the control group, the gray levels of apoptotic protein Bax/β-actin in the high glucose treatment groups of 12, 24, and 48 mmol/L were (1.29±0.25, t = 2.32, P = 0.045), (1.42±0.23, t = 10.247, P = 0.000) and (1.81±0.29, t = 16.324, P = 0.000). High glucose induced autophagy dysfunction: Compared with the control group, the gray values of autophagy-related protein Beclin-1/β-actin were (0.82±0.16, t = 4.243, P = 0.032), (0.78±0.19, t = 11.341, P = 0.000), and (0.62±0.11, t = 13.455, P = 0.000), and the gray levels of P62 protein/β-actin protein were (1.29±0.25, t = 4.442, P = 0.014), (1.42±0.23, t = 13.341, P = 0.000), and (1.81±0.29, t = 15.851, P = 0.000). The autophagy inducer rapamycin reversed high glucose-induced increase in hoechst33258-positive cells and the high-glucose-induced increase in Bax expression: Compared with the control group, the Bax /β-actin gray value of the high glucose group, high glucose and rapamycin co-treatment group, and rapamycin group rapamycin group were (1.51±0.31, t = 14.342, P = 0.000), (1.42±0.23, t = 9.621, P = 0.004), and (1.81±0.12), t = 0.172, P = 0.124).